[go: up one dir, main page]

NO991559D0 - Hydroksamsyrederivater - Google Patents

Hydroksamsyrederivater

Info

Publication number
NO991559D0
NO991559D0 NO991559A NO991559A NO991559D0 NO 991559 D0 NO991559 D0 NO 991559D0 NO 991559 A NO991559 A NO 991559A NO 991559 A NO991559 A NO 991559A NO 991559 D0 NO991559 D0 NO 991559D0
Authority
NO
Norway
Prior art keywords
acid derivatives
hydroxamic acid
hydroxamic
derivatives
acid
Prior art date
Application number
NO991559A
Other languages
English (en)
Other versions
NO313457B1 (no
NO991559L (no
Inventor
Georg Kottirsch
Ulf Neumann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620572.9A external-priority patent/GB9620572D0/en
Priority claimed from GBGB9706667.4A external-priority patent/GB9706667D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO991559D0 publication Critical patent/NO991559D0/no
Publication of NO991559L publication Critical patent/NO991559L/no
Publication of NO313457B1 publication Critical patent/NO313457B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
NO19991559A 1996-10-02 1999-03-30 Hydroksamsyrederivater NO313457B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9620572.9A GB9620572D0 (en) 1996-10-02 1996-10-02 Organic compounds
GBGB9706667.4A GB9706667D0 (en) 1997-04-02 1997-04-02 Organic compounds
PCT/EP1997/005376 WO1998014424A1 (en) 1996-10-02 1997-09-30 Hydroxamic acid derivatives

Publications (3)

Publication Number Publication Date
NO991559D0 true NO991559D0 (no) 1999-03-30
NO991559L NO991559L (no) 1999-03-30
NO313457B1 NO313457B1 (no) 2002-10-07

Family

ID=26310147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991559A NO313457B1 (no) 1996-10-02 1999-03-30 Hydroksamsyrederivater

Country Status (28)

Country Link
EP (1) EP0929517B1 (no)
JP (1) JP3444898B2 (no)
KR (1) KR20000048811A (no)
CN (1) CN1101807C (no)
AR (1) AR009103A1 (no)
AT (1) ATE219050T1 (no)
AU (1) AU726065B2 (no)
BR (1) BR9712255A (no)
CA (1) CA2267415A1 (no)
CO (1) CO4900034A1 (no)
CZ (1) CZ113999A3 (no)
DE (1) DE69713354T2 (no)
DK (1) DK0929517T3 (no)
ES (1) ES2178759T3 (no)
HU (1) HUP9903892A3 (no)
ID (1) ID22212A (no)
IL (1) IL129166A0 (no)
MY (1) MY127926A (no)
NO (1) NO313457B1 (no)
NZ (1) NZ334908A (no)
PE (1) PE2099A1 (no)
PL (1) PL188518B1 (no)
PT (1) PT929517E (no)
RU (1) RU2196131C2 (no)
SI (1) SI0929517T1 (no)
SK (1) SK43099A3 (no)
TR (1) TR199900725T2 (no)
WO (1) WO1998014424A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294917A1 (en) * 2002-12-20 2004-07-14 Novartis Ag Device and method for delivering mmp inhibitors
EP2287326A1 (en) 2003-08-08 2011-02-23 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
CA2559062A1 (en) 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
CN1951912B (zh) * 2005-10-18 2010-05-05 上海五洲药业股份有限公司 手性脂环烃异羟肟酸衍生物的制备方法
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
CN114507175B (zh) * 2016-04-18 2024-10-01 维沃里翁治疗股份有限公司 安眠蛋白α和β的新型抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
DE69502378T2 (de) * 1994-01-20 1998-10-01 British Biotech Pharm Metalloproteinaseinhibitoren
AU678884B2 (en) * 1994-01-22 1997-06-12 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
GB9416897D0 (en) * 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
CZ113999A3 (cs) 1999-06-16
KR20000048811A (ko) 2000-07-25
IL129166A0 (en) 2000-02-17
HUP9903892A3 (en) 2000-04-28
BR9712255A (pt) 1999-08-24
MY127926A (en) 2006-12-29
DK0929517T3 (da) 2002-10-07
PT929517E (pt) 2002-10-31
AR009103A1 (es) 2000-03-08
DE69713354D1 (de) 2002-07-18
NO313457B1 (no) 2002-10-07
CN1232447A (zh) 1999-10-20
EP0929517B1 (en) 2002-06-12
NZ334908A (en) 2000-10-27
PE2099A1 (es) 1999-02-08
ID22212A (id) 1999-09-16
EP0929517A1 (en) 1999-07-21
WO1998014424A1 (en) 1998-04-09
CA2267415A1 (en) 1998-04-09
ATE219050T1 (de) 2002-06-15
TR199900725T2 (xx) 1999-07-21
PL188518B1 (pl) 2005-02-28
SI0929517T1 (en) 2002-10-31
AU726065B2 (en) 2000-10-26
NO991559L (no) 1999-03-30
AU4706897A (en) 1998-04-24
JP3444898B2 (ja) 2003-09-08
PL332477A1 (en) 1999-09-13
SK43099A3 (en) 1999-08-06
CO4900034A1 (es) 2000-03-27
HK1021637A1 (en) 2000-06-23
JP2000508338A (ja) 2000-07-04
HUP9903892A2 (hu) 2000-03-28
RU2196131C2 (ru) 2003-01-10
DE69713354T2 (de) 2002-12-05
CN1101807C (zh) 2003-02-19
ES2178759T3 (es) 2003-01-01

Similar Documents

Publication Publication Date Title
IS5340A (is) Arýloxýarýlsúlfónýlamínó hýdroxamsýru afleiður
IS4958A (is) Arýlsúlfónýlamínó hýdroxamíðsýru afleiður
DE69703385D1 (de) Alkoxyessigsäure-derivate
FI951962A7 (fi) Hydroksaamihappojohdannaiset
NO993730L (no) Arylsulfonylamino-hydroksamsyrederivater
NO993836D0 (no) Arylsulfonyl-hydroksamsyre-derivater
ATE245158T1 (de) Bicyclische hydroxamsäurederivate
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
ATE323682T1 (de) Aryl-pyrimidin-derivate
NO961585D0 (no) Arylsulfonyl-hydroksamsyre-derivater
ATE261942T1 (de) 6-phenylpyridinderivate
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
DE59707658D1 (de) Glyoxylsäure-derivate
ATE219050T1 (de) Hydroxamsäure-derivate
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime
BR9506663A (pt) Derivados do ácido hidroxâmico
DE59708205D1 (de) Wässrige bleichmittel
BR1100830A (pt) Derivados de ácido heteroacético
SI1003720T1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees